News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rib-X Pharmaceuticals, Inc. Postpones IPO After Slashing Price by 50 Pct


5/11/2012 8:16:29 AM

Rib-X Pharmaceuticals Inc., an antibiotic developer based in New Haven, Conn., on Wednesday morning postponed its anticipated IPO only one day after it cut the price about 50 percent, according to information from the Nasdaq OMX Group Inc. citing Renaissance Capital. The company did not return calls for comment. A source close to the company confirmed that the IPO was postponed because of market conditions. The source said the filing is still active, and that company still is in a quiet period.

Read at Mass High Tech
Read at Nasdaq
Read at Street Insider
Read at Renaissance Capital


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES